a nonsignificant trendP =0.0608
Survival analysis based on the expression of ZEB1 alone showed a nonsignificant trend toward a modest decrease in median survival for patients with high ZEB1-expressing tumors compared with ZEB1 low tumors (15.53 and 17.97 months, respectively, P =0.0608; Supplementary Figure S4A ).